Dimitris Iakovakis (Koios Care)
Overview
Dimitris Iakovakis is a prominent figure in the field of digital health and biomedical engineering, best known as the co-founder and Chief Technology Officer (CTO) of Koios Care. This Belgian-Greek healthtech company focuses on improving neurological condition management, particularly Parkinson's Disease, through innovative digital health solutions. Iakovakis' work integrates artificial intelligence (AI) with everyday devices to yield clinically relevant insights, significantly impacting the treatment landscape for neurodegenerative disorders.
Recent Developments
In the past few years, Dimitris Iakovakis has made significant strides in expanding and enhancing the operations of Koios Care. Some of the key recent developments include:
- June 2025: Koios Care secured €1 million in a seed funding round, primarily aimed at advancing its AI-powered platform for Parkinson’s disease monitoring and care. This funding was intended to support regulatory clearance, expand market commercialization, and generate ongoing clinical evidence. It was led by the Greek early-stage deeptech fund Evercurious VC, with participation from Astylab Ventures and other investors. source
- 2024: Under Iakovakis' leadership, Koios Care conducted a successful study involving 130 patients across Europe, demonstrating their platform's effectiveness in real-world settings.
- 2023-2024: The company's platform "Parkiwatch" has been increasingly integrated into numerous EU neurological clinics, enhancing Parkinson's care through comprehensive data collection via smartphones and smartwatches.
- Early 2023: Koios Care's innovative approach to digital health for neurodegenerative disorders earned them recognition for fostering personalized, data-driven disease management at scale, gaining momentum across Europe.
Personal Information
| Attribute | Information |
|---|---|
| Full Name | Dimitris Iakovakis |
| Born | Information not available |
| Nationality | Greek |
| Occupation | Biomed Engineer, Entrepreneur |
| Known For | Co-founder and CTO of Koios Care |
| Education | PhD in Biomedical Engineering, Aristotle University of Thessaloniki |
Early Life and Education
Growing up in Greece, Dimitris Iakovakis showed an early interest in technology and health sciences, which set the foundation for his future ventures into digital health. He pursued higher education at Aristotle University of Thessaloniki, where he earned a PhD in Biomedical Engineering. His educational journey equipped him with the technical expertise and innovative mindset necessary to tackle complex health challenges, particularly in the realm of neurological disorders. During his doctoral studies, Iakovakis focused on integrating artificial intelligence with human-computer interaction to develop digital biomarkers, a focus that greatly contributed to his later work with Koios Care.
Career and Notable Achievements
Dimitris Iakovakis embarked on his professional journey as an academic researcher and software developer, which laid the groundwork for his transition into entrepreneurship.
- Co-founder of Koios Care (2022): Iakovakis co-founded Koios Care alongside Konstantinos Kyritsis. The company focuses on leveraging AI and digital health technologies for neurological diseases, starting with Parkinson's Disease.
- Notable Research: Iakovakis has published extensively in the field of digital health. His research includes the development of unobtrusive methodologies for the early detection of Parkinson's disease using AI and data from everyday devices. Noteworthy publications include work on touchscreen typing-pattern analysis and deep learning applications.
- Awards and Recognition: Throughout his career, Iakovakis has been recognized for his contributions to biomedical engineering and digital health innovation, helping transform patient care and trial methodologies in neuroscience.
Current Work and Impact
As of June 2025, Dimitris Iakovakis continues to drive innovation at Koios Care, focusing on the expansion and refinement of their "Parkiwatch" platform. The platform's ability to collect and analyze real-world data is reshaping the approach to managing neurodegenerative conditions, providing patients with better insights into their health, and aiding clinicians in making informed treatment decisions. Koios Care’s dual business model serves both patients and pharmaceutical companies, offering tools that improve patient outcomes while facilitating advanced research and drug development strategies.
Conclusion
Dimitris Iakovakis stands as a pivotal figure in the landscape of digital health innovation. His work at Koios Care is redefining how chronic neurological conditions are monitored and treated, moving towards more personalized, efficient care solutions. Looking forward, Iakovakis aims to extend Koios Care's technologies beyond Parkinson's Disease to other related conditions, thereby broadening the impact of their groundbreaking digital health solutions across the medical field. With ongoing research and development, Iakovakis’ contributions are poised to leave a lasting legacy in health technology.